PL BioScience introduced the world’s first artificial human platelet lysate (HPL), a xeno-free, lab-made cell culture supplement developed with DewCell Biotherapeutics’ artificial platelet technology.
In a recent study published in Thrombosis Research, researchers determined plasma signatures of proteins related to or derived from platelets in acute isolated pulmonary embolism (iPE) and deep vein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback